New non-invasive treatment of basal cell carcinoma

February 5, 2014, American Society for Laser Medicine & Surgery

Research conducted by H. Ray Jalian, M.D., Mathew M. Avram, M.D., J.D., Kelly J. Stankiewicz, M.D., Joshua D. Shofner, M.D., and Zeina Tannous, M.D. was selected as Editor's Choice for the January 2014 issue of Lasers in Surgery and Medicine (LSM).

The manuscript titled "Combined 585nm Pulsed-Dye and 1,064nm Nd:YAG Lasers for the Treatment of Basal Cell Carcinoma" was published in LSM, the official journal of the American Society for Laser Medicine and Surgery, Inc. (ASLMS).

Basal cell carcinoma (BCC) is the most common skin cancer diagnosed and treated in the United States today. The current traditional mainstays of therapy include surgical excision, Mohs surgery and destruction by electrodessication and cautery. More recently, studies have investigated the role of laser in providing non-invasive, scar-free of BCCs. Such treatments have the potential to treat skin cancers while reducing pain and infection without scar and without the need for sutures. A team of Harvard researchers, Jalian, et al., have just published the most recent study to determine the effect of repeated treatment with a combined pulsed dye laser (PDL) and Nd:YAG laser on BCCs.

"BCC are characterized by a specialized tumor-associated microvasculature interwoven throughout the tumor bed. By utilizing the theory of selective photothermolysis, vascular specific lasers can specifically target and destroy these abnormal blood vessels and result in the selective destruction of the BCC cells with minimal damage to the surrounding tissue. We have previously demonstrated the efficacy of other vascular specific lasers such as pulsed dye and alexandrite lasers in the treatment of BCC. In this study, we again confirm the efficacy of a combined pulsed dye and Nd:YAG vascular specific laser for BCC treatment," said Dr. Tannous.

Dr. Tannous is an associate professor and founding chairman of dermatology at Gilbert and Rose-Marie Chagoury School of Medicine, and chief of dermatology at UMC-RH. She is also on faculty at Harvard Medical School and is a graduate of the American University of Beirut School of Medicine.

According to the manuscript, "The objective of the study was to determine the effect of repeated treatment with a combined pulsed dye laser (PDL) and Nd:YAG laser on BCCs of superficial and nodular subtypes of varying diameters."

"This study reflects our continuing efforts to target the vasculature of as a method to treat them noninvasively and without scar. These findings will help us to refine further strategies for laser-based anti-angiogenesis treatments of basal cell carcinoma," commented Dr. Avram.

Dr. Avram is the director of the Massachusetts General Hospital Dermatology Laser & Cosmetic Center. He is an assistant professor of dermatology at Harvard Medical School, where he is also faculty director for procedural training in the department of dermatology.

Ten subjects with 13 biopsy-proven BCCs received four combined PDL and Nd:YAG at treatments 2–4 week intervals. None of the BCCs met the criteria for Mohs micrographic surgery. The tumor and 4 mm of peripheral skin were treated using standardized parameters delivered with a 7 mm spot with 10% overlap. The treated area was excised and evaluated histologically for residual tumor. The primary study endpoint was histologic clearance of tumor. The secondary study endpoint was blinded investigator assessment of clinical endpoint and adverse effects.

"The findings in this research study underscore the potential utility of using vascular lasers to target skin cancer. All cancers, whether they are in the skin or elsewhere, rely on a rich blood supply to support rapid growth of the tumor. Often times these blood vessels are abnormal and different from the surrounding blood vessels in the tissue. If we are able to selectively target them, then we may be able to inhibit growth of tumors. In this study, we combined two different wavelengths of light that target blood. We found that many skin cancers less than 1.5 cm cleared with a series of 4 treatments. This study also uncovered some potential reasons for treatment failure including tumors that were of a certain subclass (superficial basal cell carcinoma) and the use of blood thinners which may inhibit clot formation after laser treatment," said Dr. Jalian.

H. Ray Jalian, MD is a board certified dermatologist with advanced fellowship training in various applications of lasers and light sources in dermatology. Currently, he is clinical instructor in the Division of Dermatology at the University of California, Los Angeles. He is the author of over 20 peer reviewed manuscripts and book chapters. Current clinical and research interests include device based therapeutics for acne, treatment of vascular malformations, and tattoo removal.

The study concluded that, "Combined PDL and Nd:YAG laser is an effective means of reducing tumor burden in patients with BCC and may be a promising, emerging alternative therapy. Factors influencing treatment response includes the concomitant use of anticoagulation. Further studies are needed to investigate and optimize the utility of this treatment protocol."

The Editor-in-Chief of LSM, J. Stuart Nelson, M.D., Ph.D. commented on the study, "Current treatments for basal cell carcinoma (BCC) are largely surgical with a high risk of scarring. In the article, "Combined 585 nm Pulsed-Dye and 1064 nm Nd:YAG Lasers for the Treatment of Basal Cell Carcinoma" Jalian et al report a methodology demonstrating non-invasive treatment of BCC, selectively targeting the vasculature of these tumors with sequential pulses of two vascular lasers. Optimization of this treatment may provide clinical and histologic clearance of tumor with lower morbidity for patients, and better cosmetic outcome."

Explore further: Lasers deemed highly effective treatment for excessive scars

More information: "Combined 585nm Pulsed-Dye and 1,064nm Nd:YAG Lasers for Treatment of Basal Cell Carcinoma." Jalian, R. H., Avram, M. M., Stankiewicz, K. J., Shofner, J. D., Tannous, Z. (2014), Lasers Surg. Med., 46: 1-7. DOI: 10.1002/lsm.22201

Related Stories

Lasers deemed highly effective treatment for excessive scars

November 27, 2013
Current laser therapy approaches are effective for treating excessive scars resulting from abnormal wound healing, concludes a special topic paper in the December issue of Plastic and Reconstructive Surgery, the official ...

Superficial X-ray viable for basal, squamous cell carcinoma

August 6, 2012
(HealthDay) -- Superficial X-ray therapy remains a viable treatment for primary basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) in select patients, according to a study published online July 23 in the Journal ...

New targeted therapy to treat facial lesions

November 8, 2013
Research conducted by Roy G. Geronemus, M.D. and Yoon-Soo Cindy Bae-Harboe, M.D., was selected as Editor's Choice for the November 2013 issue of Lasers in Surgery and Medicine (LSM).

Basal cell carcinoma on ear significantly more aggressive

April 18, 2012
(HealthDay) -- Basal cell carcinoma (BCC) on the ear is significantly more likely to be aggressive, and occurs more frequently in men, according to a study published in the May issue of the Journal of the American Academy ...

Fractional, ablative er:YAG laser akin for skin resurfacing

November 10, 2012
(HealthDay)—Multiple sessions of fractional laser treatment with erbium:yttrium-aluminum-garnet (Er:YAG) for facial resurfacing are comparable to a single ablative Er:YAG laser treatment, according to a small study published ...

Lawsuits involving laser treatments by non-docs on the rise

October 16, 2013
(HealthDay)—A growing number of lawsuits over damage from skin laser treatments are tied to procedures done outside of medical offices and by non-doctors, a new study finds.

Recommended for you

Drug may help surgical patients stop opioids sooner

December 13, 2017
(HealthDay)—Opioid painkillers after surgery can be the first step toward addiction for some patients. But a common drug might cut the amount of narcotics that patients need, a new study finds.

Children best placed to explain facts of surgery to patients, say experts

December 13, 2017
Getting children to design patient information leaflets may improve patient understanding before they have surgery, finds an article in the Christmas issue of The BMJ.

Burn victim saved by skin grafts from identical twin (Update)

November 23, 2017
A man doomed to die after suffering burns across 95 percent of his body was saved by skin transplants from his identical twin in a world-first operation, French doctors said Thursday.

Is a common shoulder surgery useless?

November 21, 2017
(HealthDay)—New research casts doubt on the true effectiveness of a common type of surgery used to ease shoulder pain.

Study shows electric bandages can fight biofilm infection, antimicrobial resistance

November 6, 2017
Researchers at The Ohio State University Wexner Medical Center have shown - for the first time - that special bandages using weak electric fields to disrupt bacterial biofilm infection can prevent infections, combat antibiotic ...

Obesity increases incidence, severity, costs of knee dislocations

November 3, 2017
A new study of more than 19,000 knee dislocation cases in the U.S. between 2000 and 2012 provides a painful indication of how the nation's obesity epidemic is changing the risk, severity and cost of a traumatic injury.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.